Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1

Status

Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 2Myeloid 2Lymphoid 2Classical hematology 2

Conditions

Myelodysplastic Syndromes 140Leukemia, Myeloid, Acute 120Leukemia 98Precursor Cell Lymphoblastic Leukemia-Lymphoma 85Myeloproliferative Disorders 57Lymphoma 56Lymphoma, Non-Hodgkin 55Leukemia, Lymphocytic, Chronic, B-Cell 53Leukemia, Myeloid, Chronic-Phase 52Multiple Myeloma 51Leukemia, Myelomonocytic, Chronic 50Hodgkin Disease 49Congenital Abnormalities 47Leukemia, Myeloid, Accelerated Phase 45Leukemia, Myelogenous, Chronic, BCR-ABL Positive 45Primary Myelofibrosis 40Blast Crisis 39Anemia, Refractory, with Excess of Blasts 38Lymphoma, Follicular 37Lymphoma, Large B-Cell, Diffuse 36Lymphoma, Mantle-Cell 35Burkitt Lymphoma 35Myelodysplastic-Myeloproliferative Diseases 34Lymphoma, B-Cell, Marginal Zone 33Neoplasms, Plasma Cell 32Lymphoma, Large-Cell, Immunoblastic 31Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 31Graft vs Host Disease 24Dendritic Cell Sarcoma, Interdigitating 23Polycythemia Vera 21

Interventions

fludarabine phosphate 2fludarabine 2Busulfan 2AP 1903 reagent 2Thiotepa 1Tacrolimus 1Mycophenolic Acid 1Methylprednisolone Hemisuccinate 1Methylprednisolone 1Melphalan 1Cyclosporins 1Cyclophosphamide 1Clofarabine 1Bone Marrow Transplantation 1Alemtuzumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Hemoglobinopathies × Busulfan × Myeloid × Clear all
NCT04644016 2026-03-13

Cord Blood Transplant in Children and Young Adults With Blood Cancers and Non-malignant Disorders

Memorial Sloan Kettering Cancer Center

Phase 2 Recruiting
31 enrolled
Classical hematologyLymphoidMyeloidOther hematologic neoplasm

Bone Marrow Failure Disorders, Anemia, Refractory, with Excess of Blasts, Hemoglobinopathies, Lymphoma, Non-Hodgkin, Myeloproliferative Disorders, Leukemia, Myeloid, Acute

NCT02061800 2024-06-04

CD34+ (Malignant) Stem Cell Selection for Patients Receiving Allogenic Stem Cell Transplant

Columbia University

Phase 1/2 Active not recruiting
14 enrolled
Classical hematologyLymphoidMyeloidOther hematologic neoplasm

Neutropenia, Severe Congenital, Autosomal Recessive 3, Bone Marrow Failure Disorders, Shwachman-Diamond Syndrome, Primary Immunodeficiency Diseases, Acquired Immunodeficiency Syndrome, Anemia, Aplastic, Anemia, Sickle Cell, Hemoglobinopathies, Histiocytosis, Langerhans-Cell, Lymphoma, Myelodysplastic Syndromes, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Histiocytosis, Anemia, Diamond-Blackfan, Lymphohistiocytosis, Hemophagocytic, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Leukemia, Myelomonocytic, Juvenile, Macrophage Activation Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡